Echo Confidence Software

Empowering echocardiography with world-beating human-in-the-loop AI across 100+ measures. FDA 510(k) cleared and CE Class IIB, it delivers speed, precision, and confidence in every scan.

.
.

1cmr Software

Revolutionizing Cardiac MRI with our FDA 510 (k) cleared and CE Class IIB cleared analysis software, enhancing speed, accuracy and precision.

.
.

Corelab Services

Delivering expert imaging analysis by doctors utilizing better than human AI software with industry leading data management to support global clinical trials.

.
.

SITE QUALIFICATION

IMAGING DOCUMENTS

QUALITY CHECK

ANALYSIS





1CMR Cardiac MRI
1CMR Cardiac MRI

Cardiac MRI
and
Echocardiography

Echocardiography

Echocardiography



SPECIALISATION IN:


  • Amyloidosis (ATTR-CM)
  • Fabry’s
  • Cardiomyopathies
    (HCM, DCM, ARVC)

  • Inflammatory Cardiomyopathies
  • Heart Failure
    (HFrEF, HFpEF)
  • Myocarditis

  • Aortic Stenosis
  • Cardio-Oncology
  • Cell/Gene Therapies



Book a Demo



At MyCardium AI, we combine innovation and expertise to revolutionize cardiac imaging. From cutting-edge AI solutions like 1CMR Pro and EchoConfidence to expert Core Lab services, we’re advancing heart health with precision and efficiency.




PARTNERSHIPS

OPTUM | Change Healthcare Enterprise Imaging Healthcare



AXREM Bramble Hub Socar Research


Latest News & Updates

MyCardium AI & Optum | Change Healthcare Enterprise Imaging Healthcare:...
MyCardium AI & Optum | Change Healthcare Enterprise Imaging Healthcare: A Transformative Partnership
We are delighted to announce a major strategic partnership between MyCardium AI and Optum | Change Healthcare Enterprise Imaging Healthcare, one of the largest and most trusted enterprise imaging and PACS integration providers in the world. Th....
MyCardium AI Named One of the UK’s Top AI Startups to Watch
MyCardium AI Named One of the UK’s Top AI Startups to Watch
MyCardium AI has been recognised among the UK’s top 16 AI startups to watch, following its inclusion in Sifted’s latest feature highlighting ventures shaping the future of artificial intelligence across multiple industries. The article, based on insights from leading venture capital firms inclu....
MyCardium AI Serves as Core Laboratory in Landmark NEJM Myocardial Infarcti...
MyCardium AI Serves as Core Laboratory in Landmark NEJM Myocardial Infarction Trial
London, UK - October 2025 MyCardium AI is proud to announce its role as the Core Laboratory in the recently published NEJM study: Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction. The trial invest....
©2025 MyCardium AI
Website design by Modern Websites
At MyCardium AI, we use Google Analytics to improve your website experience.
Learn more in our Privacy Policy.
AcceptDecline
Loading Scripts...
loader